{"id":2228,"date":"2015-02-02T09:16:00","date_gmt":"2015-02-02T09:16:00","guid":{"rendered":"https:\/\/world-heart-federation.org\/news\/statements-at-the-who-executive-board-meeting\/"},"modified":"2023-01-12T15:58:54","modified_gmt":"2023-01-12T14:58:54","slug":"statements-at-the-who-executive-board-meeting","status":"publish","type":"news","link":"https:\/\/world-heart-federation.org\/news\/statements-at-the-who-executive-board-meeting\/","title":{"rendered":"Statements at the WHO Executive Board Meeting"},"content":{"rendered":"
Last week, the World Heart Federation took part in the 136th Executive Board of the WHO Executive Board and made two statements intended to ensure that cardiovascular disease (CVD) was included in the Board discussions.<\/p>\n